Alan Tomusiak

Alan Tomusiak, the founder and CEO of Permanence Bio and a PhD holder in aging biology, dives deep into innovative approaches to genome protection. He discusses the importance of stabilizing DNA to prevent age-related damage, offering a contrarian view to conventional cellular reprogramming. The conversation also highlights the role of genome stability in cancer prevention and the potential of epigenetic clocks in evaluating health. With groundbreaking insights into hematopoietic stem cells, Tomusiak presents a bold vision for enhancing longevity through DNA protection.